Ad
CAMP Short Information CalAmp Corp.
home / stock / camp / camp short
Short Information | CalAmp Corp. (NASDAQ:CAMP)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 406,951 |
| Total Actual Volume | 2,809,593 |
| Short Trends | |
|---|---|
| Cover Days | 19 |
| Short Days | 0 |
| No Change Days | 1 |
| Averages | |
|---|---|
| Average Short Volume | 20,348 |
| Average Short Percentage | 20.14% |
Is there a CAMP Short Squeeze or Breakout about to happen?
See the CAMP Short Analysis for free Sign up or Login
Powered by Squeeze Report
CAMP Twenty Trading Day's Volume to Short Volume Chart
CAMP Twenty Trading Day Price Chart
CAMP Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-22-2025 | $6.49 | $5.8 | $6.49 | $5.01 | 139,903 | 24,286 | 17.36% |
| 01-21-2025 | $4.62 | $6.54 | $6.7899 | $4.62 | 327,515 | 94,892 | 28.97% |
| 01-17-2025 | $4.52 | $4.62 | $4.625 | $4.42 | 22,314 | 6,363 | 28.52% |
| 01-16-2025 | $4.34 | $4.45 | $4.7 | $4.21 | 57,684 | 7,797 | 13.52% |
| 01-15-2025 | $3.93 | $4.41 | $4.67 | $3.52 | 58,479 | 6,682 | 11.43% |
| 01-14-2025 | $4.01 | $3.74 | $4.12 | $3.5 | 50,952 | 18,590 | 36.49% |
| 01-13-2025 | $4.3 | $3.95 | $4.46 | $3.69 | 113,924 | 22,039 | 19.35% |
| 01-10-2025 | $4.36 | $4.06 | $4.5099 | $4.04 | 192,772 | 13,885 | 7.2% |
| 01-08-2025 | $4.47 | $4.45 | $4.88 | $4.41 | 38,216 | 8,222 | 21.51% |
| 01-07-2025 | $4.6 | $4.58 | $4.94 | $4.35 | 71,876 | 17,963 | 24.99% |
| 01-06-2025 | $5.1 | $4.5 | $5.64 | $4.5 | 63,912 | 11,300 | 17.68% |
| 01-03-2025 | $5.05 | $4.95 | $5.24 | $4.74 | 64,533 | 16,595 | 25.72% |
| 01-02-2025 | $5.2315 | $4.93 | $5.64 | $4.89 | 65,265 | 13,686 | 20.97% |
| 12-31-2024 | $5.53 | $5.22 | $5.74 | $5.1 | 28,669 | 5,607 | 19.56% |
| 12-30-2024 | $5.71 | $5.41 | $5.9625 | $5.225 | 93,656 | 15,837 | 16.91% |
| 12-27-2024 | $6.46 | $5.43 | $6.7 | $5.4052 | 88,679 | 24,641 | 27.79% |
| 12-26-2024 | $6.92 | $6.49 | $7.03 | $6.01 | 77,378 | 19,575 | 25.3% |
| 12-24-2024 | $7.1 | $6.9 | $7.5 | $6.77 | 66,797 | 12,421 | 18.6% |
| 12-23-2024 | $5.2 | $7.58 | $7.69 | $5.2 | 202,752 | 36,130 | 17.82% |
| 12-20-2024 | $5.2 | $5.2 | $6.31 | $4.61 | 984,317 | 30,440 | 3.09% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing regRNA-targeting antisense oligonucleotide (ASO) therapies to upregulate gene expression to restore healthy protein levels, ...
-
Data from Single Ascending Dose (SAD) portion of Phase 1 study of CMP-CPS-001 for the treatment of urea cycle disorders (UCDs) demonstrates favorable safety results Completed dosing in the first two Multiple Ascending Dose (MAD) cohorts, and initiated dosing in Cohort 3 MAD safety and key...
-
CAMBRIDGE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protei...